+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Enfuvirtide"

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
From
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Enfuvirtide is a drug used to treat HIV infection. It is a fusion inhibitor, meaning it works by blocking the virus from entering the cells of the body. It is used in combination with other antiretroviral drugs to help reduce the amount of virus in the body and prevent further damage to the immune system. Enfuvirtide is typically used in patients who have not responded to other treatments or who have developed resistance to other drugs. It is administered as an injection and is usually taken twice daily. Enfuvirtide is a relatively new drug and is still in the early stages of development. It is not widely available and is only approved for use in certain countries. Despite this, it has been shown to be effective in treating HIV infection and is becoming increasingly popular. The Enfuvirtide market is an emerging market within the Infectious Diseases Drugs sector. It is expected to grow in the coming years as more countries approve its use and more patients become aware of its benefits. Some companies in the Enfuvirtide market include Gilead Sciences, Merck, and ViiV Healthcare. Show Less Read more